Short- and long-term efficacy of levamisole in children with steroid-sensitive nephrotic syndrome

International Urology and Nephrology

Volumn 45, Issue 4, 2013, Pages 1047-1055

  Elmas, Ahmet Taner ^a   Tabel, Yilmaz ^a   Elmas, Özlem Nalbantoǧlu ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Child; Frequently relapsing nephrotic syndrome; Levamisole; Remission rate; Steroid dependent nephrotic syndrome

Indexed keywords

LEVAMISOLE; METHYLPREDNISOLONE; PREDNISONE; PROTEIN;

ADOLESCENT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATAXIA; CHILD; CLINICAL ARTICLE; CONVULSION; CORTICOSTEROID INDUCED OSTEOPOROSIS; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERTENSION; INFECTION; LABORATORY TEST; LOW DRUG DOSE; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; NEPHROTIC SYNDROME; NEUTROPENIA; OBESITY; PRESCHOOL CHILD; PROTEINURIA; RELAPSE; REMISSION; RETROLENTAL FIBROPLASIA; SCHOOL CHILD; SHORT STATURE; SIDE EFFECT; TREATMENT DURATION; VASCULITIS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FUNCTION TESTS; LEVAMISOLE; MALE; NEPHROTIC SYNDROME; PATIENT SAFETY; PROTEINURIA; RECURRENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; STEROIDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84881478473     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0241-x     Document Type: Article

References (34)

1. Niaudet P, Boyer O (2009) İdiopathic nephrotic syndrome in children: clinical aspects. In: Avner ED, Harmon W, Niaudet P, Yoshikawa N (eds) Pediatric nephrology, 6th edn. Springer, Berlin, pp 667-673
2. Hodson E (2003) The management of idiopathic nephrotic syndrome in children. Pediatr Drugs 5:335-349
3. Hodson EM, Knight JF, Willis NS, Craig JC (2003) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev 1:CD001533
4. Takeda A, Takimoto H, Mizusawa Y, Simoda M (2001) Prediction of subsequent relapse in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 16:888-893
5. Kuhn K, Haas-Wohrle A, Lutz-Vorderbrugge A, Felten H (1998) Treatment of severe nephrotic syndrome. Kidney Int Suppl 64:S50-S53
6. Robinson RF, Nahata MC, Mahan JD, Batisky DL (2003) Management of nephrotic syndrome in children. Pharmacotherapy 23:1021-1036
7. Durkan A, Hodson E, Willis N, Craig J (2001) Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database 4:CD002290
8. Bagga A, Sharma A, Srivastata RN (1997) Levamisole therapy in corticosteroid-dependent nephrotic syndrome. Pediatr Nephrol 11:415-417
9. La Manna A, Polito C, Del Gado R, Foglia AC (1988-1989) Levamisole in children's idiopathic nephrotic syndrome. Child Nephrol Urol 9:200-202
10. Neuhaus TJ, Fay J, Dillon MJ, Trompeter RS, Barratt TM (1994) Alternative treatment to corticosteroids in steroid sensitive idiopathic nephrotic syndrome. Arch Dis Child 71:522-526
11. Brodehl J (1993) In what order should one introduce cyclophosphamide or chlorambucil, cyclosporine or levamisole in a child with steroid-dependent frequently relapsing nephrotic syndrome? Pediatric Nephrol 7:514
12. Durkan AM, Hodson EM, Willis NS, Craig JC (2001) Immunosuppressive agents in childhood nephrotic syndrome: a metaanalysis of randomized controlled trials. Kidney Int 59:1919-1927
13. Abeyagunawardena AS, Dillon MJ, Rees L, Hoff W, van't Trompeter RS (2003) The use of steroid sparing agents in steroid-sensitive nephrotic syndrome. Pediatr Nephrol 18:919-924
14. Szeto CC, Gillespie KM, Mathieeson PW (2000) Levamisole induces interleukin 18 and shifts THI/TH2 balance. Immunology 100:217-222
15. British Association for Paediatric Nephrology (1991) Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. Lancet 337:1555-1557
16. Niaudet P, Drachman R, Gagnadoux MF, Broyer M (1984) Treatment of idiopathic nephrotic syndrome with levamisole. Acta Paediatr Scand 73:637-641
17. Dayal U, Dayal AK, Shastry JC, Raghupathy P (1994) Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children. Nephron 66:408-412
18. Donia AF, Amer GM, Ahmed HA, Gazareen SH, Moustafa FE, Shoeib AA, Ismail AM, Khamis S, Sobh MA (2002) Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children. Pediatr Nephrol 17:355-358
19. Alsaran K, Grisaru S, Stephens D, Arbus G (2001) Levamisole vs. cyclophosphamide for frequently relapsing steroid-dependent nephrotic syndrome. Clin Nephrol 56:289-294
20. Al-Saran K, Mirza K, Al-Ghanam G, Abdelkarim M (2006) Experience with levamisole in frequently relapsing, steroid dependent nephrotic syndrome. Pediatr Nephrol 21:201-205
21. Sumegi V, Haszon I, Ivanyi B, Bereczki C, Papp F, Turi S (2004) Long-term effects of levamisole treatment in childhood nephrotic syndrome. Pediatr Nephrol 19:1354-1360
22. Boyer O, Moulder JK, Grandin L, Somers MJ (2008) Short- and long-term efficacy of levamisole as adjunctive therapy in childhood nephrotic syndrome. Pediatr Nephrol 23(4):575-580
23. The primary nephrotic syndrome in children (1981) Identification of patients with minimal change nephrotic syndrome from initial response to prednisone a report of the International Study of Kidney Disease in Children. J Pediatr 98(4):561-564
24. Murnaghan K, Vasmant D, Bensman A (1984) Pulse methylprednisolone therapy in severe idiopathic childhood nephrotic syndrome. Acta Paediatr Scand 73(6):733-739
25. Trompeter RS (1986) Minimal change nephrotic syndrome and cyclophosphamide. Arch Dis Child 61:727-729
26. Consensus statement on management and audit potential for steroid responsive nephrotic syndrome (1994) Report of a workshop by the British Association for Paediatric Nephrology and Research Unit. Royal College of Physicians. Arch Dis Child 70:151-157
27. International Study of Kidney Disease in Children (1982) Early identification of frequent relapsers among children with minimal change nephrotic syndrome. J Pediatr 101:514-518
28. Al-Ibrahim AA, Al-Kharraz SM, Al-Sadoon DM, Al-Madani AJ, Al-Musallam SA (2003) Levamisole therapy as a second-line Immunosuppressive agent in corticosteroid-sensitive nephrotic syndrome in children Saudi. J Kidney Dis Transpl 14(2):153-157
29. Esfahani ST, Madani A, Asgharian F, Ataei N, Roohi A, Moghtaderi M, Rahimzadeh P, Moradinejad MH (2011) Clinical course and outcome of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 26(7):1089-1093
30. Barbano G, Ginevri F, Ghiggeri GM, Gusmano R (1999) Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome. Pediatr Nephrol 13:602-603
31. Rongioletti F, Ghio L, Ginevri F, Bleidl D, Rinaldi S, Edefonti A, Gambini C, Rizzoni G, Rebora A (1999) Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol 140:948-951
32. Palcoux JB, Niaudet P, Goumy P (1994) Side effects of levamisole in children with nephrosis. Pediatr Nephrol 8:263-264
33. Dubey AK, Gupta RK, Sharma RK (2001) Levamisole induced ataxia. Indian Pediatr 38:417-419
34. Bulugahapitiya DT (1997) Liver toxicity in a nephrotic patient treated with levamisole. Arch Dis Child 76:289